Cytosorbents (CTSO) EPS (Weighted Average and Diluted) (2015 - 2026)
Cytosorbents (CTSO) reported EPS (Weighted Average and Diluted) of -$0.08 for Q1 2026, down 300.0% on a YoY basis from $0.04 in Q1 2025, and up 11.11% quarter-over-quarter from -$0.09 in Q4 2025.
Cytosorbents (CTSO) EPS (Weighted Average and Diluted) (2015 - 2026) Analysis & Trends
Cytosorbents has reported EPS (Weighted Average and Diluted) for 10 years, with the latest figure at -$0.08 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 300.0% year-over-year to -$0.08; the trailing twelve-month figure through Mar 2026 stood at -$0.19 (up 34.48% YoY), and the FY2025 full-year result was -$0.13, up 65.79% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.08, up from -$0.09 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.03 in Q2 2025, with the low at -$0.28 in Q3 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.12 across 5 years, with a median of -$0.11 in 2024.
- Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) slumped 500.0% — and 2025, when it jumped 137.5%.
- Cytosorbents' EPS (Weighted Average and Diluted) stood at -$0.02 in 2022, then tumbled by 500.0% to -$0.12 in 2023, then fell by 16.67% to -$0.14 in 2024, then surged by 35.71% to -$0.09 in 2025, then advanced by 11.11% to -$0.08 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.08 (Q1 2026), -$0.09 (Q4 2025), and -$0.05 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | -0.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.08 |
| Dec 31, 2025 | -0.09 |
| Sep 30, 2025 | -0.05 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | -0.14 |
| Sep 30, 2024 | -0.05 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -0.11 |
| Dec 31, 2023 | -0.12 |
| Sep 30, 2023 | -0.21 |
| Jun 30, 2023 | -0.15 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.28 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.21 |
| Dec 31, 2021 | -0.25 |
| Sep 30, 2021 | -0.15 |
| Jun 30, 2021 | -0.11 |